15 unchanged sentences
Not Applicable.
−Removed: Other Information.
−Removed: Trading Arrangements
−Removed: During the quarter ended June 30, 2025 , none of our directors or officers adopted or terminated any Rule 10b5 - 1 trading arrangement or any non-Rule 10b5 - 1 trading arrangement (as such terms are defined pursuant to Item 408 (a) of Regulation S-K).
−Removed: Incorporated by Reference
−Removed: Amended and Restated Certificate of Incorporation of the Registrant.
−Removed: Amended and Restated Bylaws of the Registrant.
−Removed: Offer Letter, dated as of April 3, 2025, by and between the Registrant and Tim Watkins.
−Removed: Amendment to Offer Letter, dated as of April 18, 2025, by and between the Registrant and Tim Watkins.
−Removed: Sales Agreement, dated May 14, 2025, by and between Contineum Therapeutics, Inc.
−Removed: and Leerink Partners.
−Removed: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Principal Executive Officer Pursuant to 18 U.S.C.
−Removed: Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Principal Financial Officer Pursuant to 18 U.S.C.
−Removed: Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
−Removed: Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
−Removed: Cover Page Interactive Data File (embedded within the Inline XBRL document).
−Removed: _________________________________________
−Removed: + Indicates management contract or compensatory plan.
−Removed: Pursuant to Item 601(a)(5) of Regulation S-K, certain exhibits and schedules have been omitted.
−Removed: The Registrant hereby undertakes to furnish supplementally a copy of any omitted exhibit or schedule upon request by the SEC.
−Removed: * The certifications furnished in Exhibit 32.1 and 32.2 hereto are deemed to be furnished with this Quarterly Report on Form 10-Q and will not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates them by reference.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: Contineum Therapeutics, Inc.
−Removed: August 5, 2025
−Removed: /s/ Carmine Stengone
−Removed: Carmine Stengone
−Removed: President, Chief Executive Officer and Director
−Removed: (Principal Executive Officer)
−Removed: August 5, 2025
−Removed: /s/ Peter Slover
−Removed: Chief Financial Officer
−Removed: (Principal Financial Officer and Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.